VOLITIONRX LTD — Director's Dealing 2015

Dec 18, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2015-12-09

Reporting Person: Micallef Jacob Vincent (Chief Scientific Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-12-09	Common Stock	M	50000	$3.01	Acquired	64290	Indirect
2015-12-09	Common Stock	F	35834	$4.2	Disposed	28456	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-12-13	Stock Option (Right to Buy)	$3.01	M	50000	Disposed	2015-12-13	Common Stock (50000)	Indirect

Footnotes

F1: These shares of Common Stock are owned of record by Borlaug Limited, which is a consulting firm. Dr. Micallef is a controlling director of Borlaug Limited and has voting and dispositive control over these shares. However, Dr. Micallef disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

F2: These options to purchase Common Stock were granted pursuant to the Issuer's 2011 Equity Incentive Plan dated November 17, 2011, and are owned of record by Borlaug Limited, which is a consulting firm. Dr. Micallef is a controlling director of Borlaug Limited and has voting and dispositive control over the shares of Common Stock issuable to Borlaug Limited upon the exercise of these options. However, Dr. Micallef disclaims benefical ownership of the Options except to the extent of his pecuniary interest therein.